Antidepressants have become a common part of healthcare in the United States, with about 1 in 6 American adults taking the medications, according to recent research. Their use has also increased as anxiety and depression have become more common, particularly since the COVID-19 pandemic.
That trend has prompted a growing debate over whether these medications are being prescribed too often. Some researchers have raised concerns about unnecessary treatment and the challenges some patients face when they eventually decide they want to stop taking their medication.
The reality, however, is more complicated than simply counting prescriptions.
Antidepressants can provide meaningful benefits for people experiencing moderate to severe depression. At the same time, they may not always be the most appropriate first choice for people experiencing milder symptoms, when other forms of care can sometimes be effective.
The distinction matters because the word depression is frequently used to describe a wide range of experiences, from temporary sadness to a serious medical condition requiring treatment.
Primary care plays a major role
More than half of antidepressant prescriptions are for selective serotonin reuptake inhibitors, commonly known as SSRIs. Fluoxetine, sold under the brand name Prozac, became the first SSRI approved in the U.S. in 1987.
Today, antidepressants are often prescribed outside specialized mental health settings. Most prescriptions are written by primary care providers rather than psychiatrists, according to a 2026 analysis.
Primary care offices can be an important place for identifying mental health concerns because patients may already feel comfortable seeking care there. But these clinicians can face limitations when it comes to offering alternatives to medication, including access to therapy and specialized psychiatric support.
Depression screening questionnaires can also help identify people who may need additional evaluation. However, a screening score alone does not necessarily provide enough information to determine whether someone needs medication.
A person experiencing a difficult period could potentially receive a concerning screening result without having a condition that requires long term medication. At the same time, screening can miss people who genuinely need additional support.
Access to care has changed
The increase in antidepressant use also reflects broader changes in how Americans receive mental healthcare.
The pandemic accelerated the use of telehealth, making it easier for many people to consult healthcare professionals from home. Before the pandemic, only a small share of antidepressant prescriptions were connected to telehealth visits. By 2022, that figure had risen to roughly one third.
For some patients, virtual care can make seeking help feel more convenient and private. It can also reduce some of the barriers associated with visiting a dedicated mental health clinic.
That expanded access is important because many Americans experiencing serious depression still receive limited or no treatment. A rise in prescriptions, therefore, does not necessarily mean that everyone taking an antidepressant is receiving unnecessary care.
Why the debate is more complicated
There are legitimate reasons to question whether antidepressants are sometimes prescribed when another approach might be more appropriate. Some people taking the medications may receive little benefit, while others could potentially improve with therapy, lifestyle changes or another form of support.
But the increase in prescriptions can also reflect people who previously struggled to obtain mental healthcare finally getting treatment.
The larger issue may be how the U.S. healthcare system is structured. Primary care providers are well positioned to identify mental health concerns, yet patients may have difficulty obtaining specialized services afterward. Clinicians may also have limited resources to help patients pursue nonmedication approaches.
That can leave medication as the most practical option, even when a broader treatment plan might be preferable.
Stopping medication requires careful planning
Another concern involves what happens when patients decide they no longer want to take an antidepressant.
The body can adapt to medications over time, and abruptly stopping certain antidepressants can produce withdrawal symptoms. These may include headaches, sleep difficulties, flu like feelings and unusual sensations in the head.
A 2024 review of numerous studies found that about one-quarter of people who stopped antidepressants experienced some withdrawal symptoms, while about 3% experienced severe symptoms.
For that reason, people who have taken antidepressants for an extended period generally should not stop suddenly without guidance from a healthcare professional. A gradual reduction in dosage over weeks or months may be appropriate, depending on the medication and the individual.
Ultimately, the question is not simply whether Americans are taking too many antidepressants. The bigger issue is whether each person is receiving the right treatment for their circumstances, with access to medication, therapy and other options when appropriate.
For some people, antidepressants medication can be an important part of long-term care. For others, a different approach may make more sense. The key is ensuring that those decisions are made with qualified healthcare guidance rather than relying solely on prescription trends.
